Li Kang Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	95.7	64.95	111.84	132.01	101.36	98.1
Short-Term Investments	126.02	373.6	173.53	117.5	62.5	110
Trading Asset Securities	15.26	15.86	15.66	13.92	11.89	12.5
Cash & Short-Term Investments	236.98	454.4	301.02	263.43	175.75	220.59
Cash Growth	-48.55%	50.95%	14.27%	49.89%	-20.33%	13.74%
Accounts Receivable	9.84	9.51	9.27	10.18	8.08	7.45
Receivables	9.84	9.51	9.27	10.18	8.08	7.45
Inventory	58.17	45.08	41.59	33.65	31.13	34.08
Prepaid Expenses	-	-	-	2.03	1.27	0.44
Other Current Assets	12.7	3.71	3.8	-	-	-
Total Current Assets	317.69	512.71	355.68	309.29	216.23	262.56
Property, Plant & Equipment	742.54	420.49	365.63	276.68	362.41	370.66
Long-Term Investments	14.91	19.38	20.88	25.38	26.04	-
Other Intangible Assets	1.05	1.93	1.08	1.68	0.24	0.11
Long-Term Deferred Tax Assets	0.41	0.61	0.52	-	0.1	0.06
Other Long-Term Assets	80.43	80.5	83.21	75.81	11.06	11.38
Total Assets	1,157	1,036	827.01	688.84	616.07	644.77
Accounts Payable	96.65	35.92	27.96	43.9	29.46	27.52
Accrued Expenses	30.64	37.55	43.32	39.54	30.99	32.03
Current Portion of Long-Term Debt	-	5.36	3.65	-	8.88	8.2
Current Portion of Leases	2.8	0.9	-	-	-	-
Current Income Taxes Payable	2.37	7.46	28.67	28.54	12.09	17.79
Other Current Liabilities	7.94	6.86	6.08	6.63	6.92	7.2
Total Current Liabilities	260.39	94.05	109.69	118.61	88.34	92.73
Long-Term Debt	-	29.64	31.35	-	24.59	32.79
Long-Term Leases	52.95	56.02	55.84	-	-	-
Long-Term Deferred Tax Liabilities	0.07	0.22	0.09	0.09	-	-
Other Long-Term Liabilities	-	-	-	-	11.14	10.94
Total Liabilities	313.41	179.93	196.97	118.7	124.07	136.46
Common Stock	318.07	318.07	268.07	233.1	222	222
Additional Paid-In Capital	213.39	213.39	33.75	33.72	33.72	33.63
Retained Earnings	328.95	336.56	339.05	309.64	241.95	252.67
Comprehensive Income & Other	-16.8	-12.33	-10.83	-6.33	-5.67	-
Shareholders' Equity	843.61	855.68	630.03	570.14	492	508.3
Total Liabilities & Equity	1,157	1,036	827.01	688.84	616.07	644.77
Total Debt	175.75	91.92	90.84	-	33.47	40.99
Net Cash (Debt)	61.23	362.48	210.19	263.43	142.28	179.61
Net Cash Growth	-83.41%	72.46%	-20.21%	85.15%	-20.78%	24.07%
Net Cash Per Share	1.92	11.62	7.80	9.77	5.28	6.65
Filing Date Shares Outstanding	31.81	31.81	26.81	26.81	26.81	26.81
Total Common Shares Outstanding	31.81	31.81	26.81	26.81	26.81	26.81
Working Capital	57.29	418.66	245.99	190.68	127.89	169.83
Book Value Per Share	26.52	26.90	23.50	21.27	18.35	18.96
Tangible Book Value	842.56	853.75	628.95	568.46	491.76	508.19
Tangible Book Value Per Share	26.49	26.84	23.46	21.21	18.34	18.96
Land	127.19	127.19	127.19	127.19	199.16	199.16
Buildings	226.88	226.88	224.6	224.6	227.62	224.12
Machinery	47.54	47	41.18	41.55	43.05	42.91
Construction In Progress	389.61	58.96	-	-	0.83	0.83
Leasehold Improvements	3.14	2.75	1.06	0.63	0.63	0.47

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.